Human immunodeficiency virus i infection Clinical Trials
Conditions / Human immunodeficiency virus i infection
Delta Trials records 13 clinical trials for Human immunodeficiency virus i infection in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 9 trials have reached completion. This research is conducted across 15 study locations around the world. An additional 3 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
13
Total Trials
1
Recruiting
9
Completed
3
Other Active
1
Terminated since 2020
15
Study Locations
Browse by location (15 total)
- Fort Lauderdale, United States 2 trialsAll trials in Fort Lauderdale, United States
- Washington D.c, United States 1 trialAll trials in Washington D.c, United States
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States
- Mwanza, Tanzania 1 trialAll trials in Mwanza, Tanzania
- Richmond, Canada 1 trialAll trials in Richmond, Canada
- Lyon, France 1 trialAll trials in Lyon, France
- Vancouver, Canada 1 trialAll trials in Vancouver, Canada
- Victoria, Canada 1 trialAll trials in Victoria, Canada
- New York, United States 1 trialAll trials in New York, United States
- Shatin, Hong Kong 1 trialAll trials in Shatin, Hong Kong
- Chapel Hill, United States 1 trialAll trials in Chapel Hill, United States
- Cleveland, United States 1 trialAll trials in Cleveland, United States
- Seattle, United States 1 trialAll trials in Seattle, United States
- Uyo, Nigeria 1 trialAll trials in Uyo, Nigeria
- Shenzhen, China 1 trialAll trials in Shenzhen, China
- Brussels, Belgium 1 trialAll trials in Brussels, Belgium